Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 1
2005 3
2006 2
2007 4
2008 2
2009 1
2010 2
2011 4
2012 4
2013 4
2014 4
2015 2
2016 3
2017 3
2018 5
2019 10
2020 3
2021 7
2022 9
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean qingxia chen (154 results)?
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, Shao G, Zhang B, Shan Y, Meng Z, Wu J, Gu S, Yang W, Liu C, Shi X, Gao Z, Yin T, Cui J, Huang M, Xing B, Mao Y, Teng G, Qin Y, Wang J, Xia F, Yin G, Yang Y, Chen M, Wang Y, Zhou H, Fan J; ORIENT-32 study group. Ren Z, et al. Among authors: chen m. Lancet Oncol. 2021 Jul;22(7):977-990. doi: 10.1016/S1470-2045(21)00252-7. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143971 Clinical Trial.
A Nature-Inspired Versatile Bio-Adhesive.
Chen M, Chen T, Bai J, He S, Luo M, Zeng Y, Peng W, Zhao Y, Wang J, Zhu X, Zhi W, Weng J, Zhang K, Zhang X. Chen M, et al. Adv Healthc Mater. 2023 Nov;12(29):e2301560. doi: 10.1002/adhm.202301560. Epub 2023 Aug 13. Adv Healthc Mater. 2023. PMID: 37548628
Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections: A Phase IIb Randomized Clinical Trial.
Wei Y, Wu J, Chen Y, Fan K, Yu X, Li X, Zhao Y, Li Y, Lv G, Song G, Rong X, Lin C, Wang H, Chen X, Zhang P, Han C, Zu H, Liu W, Zhang Y, Liu C, Su Y, Zhang B, Sun B, Wang L, Lai W, Liu J, Xia C, Ji G, Zhu F, Yu J, Ahemaiti A, Dong H, Chen M; PL-5 Investigators. Wei Y, et al. Among authors: chen m. Ann Surg. 2023 Jan 1;277(1):43-49. doi: 10.1097/SLA.0000000000005508. Epub 2022 Jul 4. Ann Surg. 2023. PMID: 35781462 Free PMC article. Clinical Trial.
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.
Shi GM, Huang XY, Wen TF, Song TQ, Kuang M, Mou HB, Bao LQ, Zhao HT, Zhao H, Feng XL, Zhang BX, Peng T, Zhang YB, Li XC, Yu HS, Cao Y, Liu LX, Zhang T, Wang WL, Ran JH, Liu YB, Gong W, Chen MX, Cao L, Luo Y, Wang Y, Zhou H, Yang GH, Fan J, Zhou J. Shi GM, et al. Cancer Med. 2023 Feb;12(4):4137-4146. doi: 10.1002/cam4.5273. Epub 2022 Sep 20. Cancer Med. 2023. PMID: 36127767 Free PMC article. Clinical Trial.
3D printing in intertrochanteric fractures of the femur.
Wang H, Chen M, Wu Y, Ge J. Wang H, et al. Among authors: chen m. Minerva Pediatr (Torino). 2023 Aug;75(4):627-629. doi: 10.23736/S2724-5276.23.07226-9. Epub 2023 Mar 23. Minerva Pediatr (Torino). 2023. PMID: 36951133 Free article. No abstract available.
88 results